KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab ; volume:13 ; number:1 ; day:29 ; month:11 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (29.11.2023), 1-10, 12.2023
- Creator
-
Chiari, Rita
Palladino, Silvia
Emili, Rita
Lisa, Mariagrazia De
Sarti, Donatella
Catalano, Vincenzo
Magnani, Mauro
Graziano, Francesco
Ruzzo, Annamaria
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-48304-0
- URN
-
urn:nbn:de:101:1-2024021521094269054970
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chiari, Rita
- Palladino, Silvia
- Emili, Rita
- Lisa, Mariagrazia De
- Sarti, Donatella
- Catalano, Vincenzo
- Magnani, Mauro
- Graziano, Francesco
- Ruzzo, Annamaria
- SpringerLink (Online service)
Other Objects (12)
Pembrolizumab
Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
Pembrolizumab for all
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
Pembrolizumab: The Nut Cracker
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Pembrolizumab-Induced Delayed-Onset Hepatitis
Pembrolizumab Treatment-Induced Liver Toxicity
Pembrolizumab
Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
Pembrolizumab for all
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
Pembrolizumab: The Nut Cracker
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Pembrolizumab-Induced Delayed-Onset Hepatitis
Pembrolizumab Treatment-Induced Liver Toxicity
Pembrolizumab
Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
Pembrolizumab for all
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
Pembrolizumab: The Nut Cracker
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Pembrolizumab-Induced Delayed-Onset Hepatitis